Designed as a next generation cellulose-based virus removal filter, Planova™ S20N has demonstrated robust filtration ...
These results back up results from the TEMPO-3 trial, which tested tavapadon as an add-on therapy to levodopa and which also ...
The US big pharma company Pfizer has voluntarily withdrawn the oral sickle cell disease treatment Oxbryta from the market and ...
The US biotech’s neurological drug candidate showed a reduction in disease progression of at least 50% and the company will ...
The small molecule drug arimoclomol (Miplyffa) has got the green light from the U.S. Food and Drug Administration (FDA) for ...
As department lead, I am responsible for determining the overall direction of our engineering and extraction technology team at Bioiberica. It’s a great team to lead comprised of 15 scientists, with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback